Get Premium to unlock powerful stock data
Sanofi SA logo

Sanofi SA

$ 54.40 +1.34 (+2.53%) 10:08 PM EST
On watch
P/E:
20.67
P/B:
1.87
Market Cap:
$ 135.85B
Enterprise V:
$ 147.03B
Volume:
1.86M
Avg Vol (2M):
2.24M
Also Trade In:
Volume:
1.86M
Market Cap $:
135.85B
PE Ratio:
20.67
Avg Vol (2-Month):
2.24M
Enterprise Value $:
147.03B
PB Ratio:
1.87
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for Sanofi SA () from 2002 to May 22 2022. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Sanofi stock (SNY) PE ratio as of May 22 2022 is 20.67. More Details

Sanofi PE Ratio (TTM) Chart

EMBED

Sanofi PE Ratio (TTM) Historical Data

Total 1244
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Sanofi PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2022-05-2218.9 2022-03-2117.7
2022-05-2018.9 2022-03-1818.1
2022-05-1918.4 2022-03-1718.3
2022-05-1818.2 2022-03-1618.0
2022-05-1718.4 2022-03-1518.0
2022-05-1618.3 2022-03-1417.5
2022-05-1318.1 2022-03-1117.6
2022-05-1217.8 2022-03-1017.9
2022-05-1117.6 2022-03-0918.0
2022-05-1018.1 2022-03-0817.4
2022-05-0917.7 2022-03-0716.9
2022-05-0617.9 2022-03-0416.8
2022-05-0517.9 2022-03-0317.4
2022-05-0418.2 2022-03-0217.7
2022-05-0318.6 2022-03-0117.7
2022-05-0218.4 2022-02-2818.2
2022-04-2918.1 2022-02-2518.4
2022-04-2818.9 2022-02-2417.8
2022-04-2718.9 2022-02-2318.2
2022-04-2618.7 2022-02-2218.1
2022-04-2518.9 2022-02-2118.2
2022-04-2218.8 2022-02-1818.2
2022-04-2119.2 2022-02-1718.4
2022-04-2019.4 2022-02-1618.6
2022-04-1919.2 2022-02-1518.4
2022-04-1819.2 2022-02-1418.1
2022-04-1519.4 2022-02-1118.3
2022-04-1419.4 2022-02-1018.4
2022-04-1319.7 2022-02-0918.6
2022-04-1219.4 2022-02-0818.6
2022-04-1120.0 2022-02-0718.4
2022-04-0819.7 2022-02-0418.1
2022-04-0719.3 2022-02-0318.2
2022-04-0618.8 2022-02-0218.3
2022-04-0518.4 2022-02-0117.9
2022-04-0418.3 2022-01-3118.1
2022-04-0118.1 2022-01-2818.3
2022-03-3117.8 2022-01-2718.4
2022-03-3017.9 2022-01-2617.8
2022-03-2917.9 2022-01-2517.9
2022-03-2818.0 2022-01-2417.7
2022-03-2517.9 2022-01-2117.8
2022-03-2417.8 2022-01-2018.1
2022-03-2317.9 2022-01-1918.1
2022-03-2218.0 2022-01-1818.1

Sanofi PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Sanofi SA logo

Business Description

Industry
Healthcare » Drug Manufacturers » NAICS : 325412 SIC : 2834
Address
54, Rue La Boetie, Paris, FRA, 75008
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.